Adaptive Biotechnologies Corp Stock Story

ADPT Stock  USD 2.89  0.01  0.35%   
Slightly above 58% of Adaptive Biotechnologies' investor base is looking to short. The analysis of overall sentiment of trading Adaptive Biotechnologies Corp stock suggests that many investors are alarmed at this time. Adaptive Biotechnologies' investor sentiment overview provides quick insight into current market opportunities from investing in Adaptive Biotechnologies Corp. The current market sentiment, together with Adaptive Biotechnologies' historical and current headlines, can help investors time the market. In addition, many technical investors use Adaptive Biotechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Adaptive Biotechnologies stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Adaptive daily returns and investor perception about the current price of Adaptive Biotechnologies Corp as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Adaptive Biotechnologies Corp.

Adaptive Biotechnologies Latest Timeline

Adaptive Biotechnologies is listed for 2.89. The company currently holds 229.43 M in liabilities with Debt to Equity (D/E) ratio of 0.21, which may suggest the company is not taking enough advantage from borrowing. Adaptive Biotechnologies has a current ratio of 3.85, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Adaptive Biotechnologies until it has trouble settling it off, either with new capital or with free cash flow. So, Adaptive Biotechnologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Adaptive Biotechnologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Adaptive to invest in growth at high rates of return. When we think about Adaptive Biotechnologies' use of debt, we should always consider it together with cash and equity.
When determining whether Adaptive Biotechnologies is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Adaptive Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Adaptive Biotechnologies Corp Stock. Highlighted below are key reports to facilitate an investment decision about Adaptive Biotechnologies Corp Stock:

Complementary Tools for Adaptive Stock analysis

When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Adaptive Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adaptive Biotechnologies. If investors know Adaptive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adaptive Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.56)
Revenue Per Share
1.179
Quarterly Revenue Growth
(0.17)
Return On Assets
(0.17)
Return On Equity
(0.58)
The market value of Adaptive Biotechnologies is measured differently than its book value, which is the value of Adaptive that is recorded on the company's balance sheet. Investors also form their own opinion of Adaptive Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adaptive Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adaptive Biotechnologies' market value can be influenced by many factors that don't directly affect Adaptive Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adaptive Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adaptive Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adaptive Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.